Shanghai Changzheng Hospital

This early-phase study tests a new drug (LC-K76) combined with an immunotherapy (anti-PD-1) and hormone therapy in 10 men whose metastatic prostate cancer has worsened after standard treatments. The main goal is to check safety, with early signs of tumor control also measured. Th…

This early-phase study tests a new drug called LC-K76 combined with standard hormone therapy in 40 men with metastatic hormone-sensitive prostate cancer. The main goal is to check safety and side effects, while also looking at how well it controls the cancer, such as lowering PSA…

This study is testing a new blood test that uses advanced quantum sensors and artificial intelligence to find tiny bits of DNA from prostate cancer cells. The goal is to diagnose prostate cancer earlier and more accurately than current methods, potentially reducing the need for i…

This study will follow 150 adults with paralysis from spinal tumors who undergo surgery to relieve pressure on the spinal cord. Researchers will track how well patients regain movement, bladder and bowel control, and quality of life over one year. The goal is to identify which fa…

This study looks at whether giving radiotherapy after surgery for spinal metastases (cancer that has spread to the spine) helps patients live longer or have better outcomes. Researchers will follow 130 adults who have already had surgery to compare those who receive radiotherapy …